Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
23.38
-0.36 (-1.52%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Nurix Therapeutics Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Nurix Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $33. The average 1-year stock price forecast is 41.15% higher than the current stock price, while the lowest is $25 (+6.93%) and the highest is $45 (+92.47%).
Price Target: $33 (+41.15%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 10 | 9 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 16 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Reiterates $23 → $31 | Buy | Reiterates | $23 → $31 | +32.59% | Jul 22, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $25 | Hold | Maintains | $25 | +6.93% | Jul 14, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $30 → $34 | Buy | Maintains | $30 → $34 | +45.42% | Jul 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $28 | Buy | Maintains | $28 | +19.76% | Jul 10, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $30 → $33 | Buy | Reiterates | $30 → $33 | +41.15% | Jul 10, 2026 |
Financial Forecast
Revenue This Year
57.74M
from 83.98M
Decreased by -31.25%
Revenue Next Year
96.40M
from 57.74M
Increased by 66.95%
EPS This Year
-2.72
from -3.05
EPS Next Year
-2.15
from -2.72
EPS and Forward PE are based on non-GAAP adjusted numbers.